Lack of B7-1 and B7-2 costimulatory molecules modulates the severity of group B Streptococcus-induced arthritis

Microbes and Infection

Volumn 12, Issue 4, 2010, Pages 302-308

  Puliti, Manuela ^a   Bistoni, Francesco ^a   Tissi, Luciana ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL ARTHRITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; GROUP B STREPTOCOCCAL INFECTION; IMMUNOMODULATION; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; STREPTOCOCCUS AGALACTIAE;

ANIMALS; ANTIGENS, CD80; ANTIGENS, CD86; ARTHRITIS, INFECTIOUS; COLONY COUNT, MICROBIAL; CYTOKINES; FEMALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; SEPSIS; STREPTOCOCCUS AGALACTIAE; SURVIVAL ANALYSIS;

MUS; STREPTOCOCCUS SP. 'GROUP B';

EID: 77649274202     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2010.01.006     Document Type: Article

References (30)

1. Baker C.J., and Edwards M.S. Group B streptococcal infection. In: Remington J.S., and Klein J.O. (Eds). Infectious Diseases of the Fetus and Newborn Infants (1995), W.B. Saunders, Philadelphia 980-1054
2. Perovic O., Crewe-Brown H.H., Khoosal M., and Karstaedt A.S. Invasive group B streptococcal disease in nonpregnant adults. Eur. J. Clin. Microbiol. Infect. Dis. 18 (1999) 362-364
3. Farley M.M. Group B streptococcal disease in nonpregnant adults. Clin. Infect. Dis. 33 (2001) 556-561
4. Garcia-Lechuz J.M., Bachiller P., Vassallo F.J., Munoz P., Padilla B., and Bouz E. Group B streptococcal osteomyelitis in adults. Medicine (Baltimore) 78 (1999) 191-199
5. Small C.B., Slater L.M., Lowy F.D., Small R.D., Salvati E.A., and Casey J.I. Group B streptococcal arthritis in adults. Am. J. Med. 76 (1984) 367-375
6. Laster A.J., and Michels M.L. Group B streptococcal arthritis in adults. Am. J Med. 76 (1984) 910-915
7. Nolla J.M., Gomez-Vaquero C., Corbella X., Ordonez S., Garcia-Gomez C., Perez A., Cabo J., Valverde J., and Ariza J. Group B streptococcus (Streptococcus agalactiae) pyogenic arthritis in nonpregnant adults. Medicine 82 (2003) 119-128
8. Dubost J.J., Soubrier M., De Champs C., Ristori J.M., and Sauvezie B. Streptococcal septic arthritis in adults. A study of 55 cases with a literature review. Joint Bone Spine 71 (2004) 303-311
9. Tissi L., Marconi P., Mosci P., Merletti L., Cornacchione P., Rosati E., Recchia S., von Hunolstein C., and Orefici G. Experimental model of type IV Streptococcus agalactiae (group B Streptococcus) infection in mice with early development of septic arthritis. Infect. Immun. 58 (1990) 3093-3100
10. Tissi L., von Hunolstein C., Bistoni F., Marangi M., Parisi L., and Orefici G. Role of group B streptococcal capsular polysaccharides in the induction of septic arthritis. J. Med. Microbiol. 47 (1998) 717-723
11. Puliti M., Nizet V., von Hunolstein C., Bistoni F., Mosci P., Orefici G., and Tissi L. Severity of group B streptococcal arthritis is correlated with β-hemolysin expression. J. Infect. Dis. 182 (2000) 824-832
12. Puliti M., von Hunolstein C., Bistoni F., Mosci P., Orefici G., and Tissi L. Influence of interferon-γ administration on the severity of experimental group B streptococcal arthritis. Arthritis Rheum. 43 (2000) 2678-2686
13. Tissi L., Puliti M., Barluzzi R., Orefici G., von Hunolstein C., and Bistoni F. Role of tumor necrosis factor alpha, interleukin-1β and interleukin-6 in a mouse model of group B streptococcal arthritis. Infect. Immun. 67 (1999) 4545-4550
14. Anguita J., Roth R., Samanta S., Gee R.J., Barthold S.W., Mamula M., and Fikrig E. B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis. Infect. Immun. 65 (1997) 3037-3041
15. + regulatory T-cells are essential components of the memory-protective immunity to Candida albicans. J. Immunol. 169 (2002) 6298-6308
16. Chen C., and Natavi N. In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2. Immunity 1 (1994) 147-154
17. Janeway C.A.J., and Bottomly K. Signals and signs for lymphocyte responses. Cell 76 (1994) 275-285
18. Thompson C.B. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation?. Cell 81 (1995) 979-982
19. Kuchroo V.K., Das M.P., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A., Weiner H.L., Nababi N., and Glimcher L.H. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80 (1995) 707-718
20. Iwai H., Kozono Y., Hirose S., Akiba H., Yagita H., Okomura K., Kohsaka H., Miyasaka N., and Azuma M. Amelioration of collagen-induced arthritis bu blockade of inducible costimulator-B7 homologous protein costimulation. J. Immunol. 169 (2002) 4332-4339
21. Tissi L., Mc Rae B., Ghayur T., von Hunolstein C., Orefici G., Bistoni F., and Puliti M. Role of interleukin-18 in experimental group B streptococcal arthritis. Arthritis Rheum. 50 (2004) 2005-2013
22. Webb L.M., Walmsley M.J., and Feldmann M. Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2. Eur. J. Immunol. 26 (1996) 2320-2328
23. Odobasic D., Leech M.T., Xue J.R., and Holdsworth S.R. Distinct in vivo roles of CD80 and CD86 in the effector T-cell responses inducing antigen-induced arthritis. Immunology 124 (2008) 503-513
24. Zwerina J., Redlich K., Schett G., and Smolen J.S. Pathogenesis of rheumatoid arthritis: targeting cytokines. Ann. N. Y. Acad. Sci. 1051 (2005) 716-729
25. Plater-Zyberk C., Joosten L.A.B., Helsen M.M., Sattonnet-Roche P., Siegfried C., Alouani S., van De Loo F.A., Graber P., Aloni S., Cirillo R., Lubberts E., Dinarello C.A., van Den Berg W.B., and Chvatchko Y. Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J. Clin. Invest. 108 (2001) 1825-1832
26. Szekanecz Z., and Koch A.E. Chemokines and angiogenesis. Curr. Opin. Rheumatol. 13 (2001) 202-204
27. Kobayashi M., Squires G.R., Mousa A., Tanzer M., Zukor D.J., Antoniou J., Feige U., and Poole A.R. Role of interleukin-1 and tumor necrosis factor-a in matrix degradation of human osteoartritic cartilage. Arthritis Rheum. 52 (2005) 128-135
28. Joosten L.A.B., Lubberts E., Durets P., Helsen M.M.A., Jacobs M.J., Goldman M., and van den Berg W.B. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis: protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. 40 (1997) 249-260
29. Lubberts E., Joosten A.B., Helsen M.M.A., and van den Berg W.B. Regulatory role of interlukin-10 in joint inflammation and cartilage destuction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefits with IL-4/IL-10 combination therapy than with IL-10 treatment alone. Cytokine 10 (1998) 361-369
30. Tissi L., Bistoni F., and Puliti M. IL-4 deficiency decreases mortality but increases severity of arthritis in experimental group B streptococcal infection. Mediators Inflamm. (2009) 394021 (E-Pub)